Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
Twitter Feed
-
We’re excited to announce our collaboration with https://t.co/SQ66Kw0JqC to leverage the power of cutting-edge technology in combination with our expertise in the #neurology space to help optimize care for people living with #MyastheniaGravis https://t.co
— UCB News (@ucb_news) 23.11.2020 -
Our thoughts go out to the family and friends of Patrick Quinn. His activism and famous Ice Bucket Challenge have left a lasting legacy and improved knowledge, awareness and research into this devastating illness. #PatrickQuinn #ALS #IceBucketChallenge ht
— UCB News (@ucb_news) 23.11.2020 -
#AdvantageHers is inspired by @CaroWozniacki and her determination to live well with a chronic inflammatory disease. Click for support and resources, including a guide to help women with these conditions talk to their healthcare team about their needs.
— UCB News (@ucb_news) 20.11.2020
Instagram Feed
At UCB, we take our responsibility
to the planet very seriously.
UCB Ventures, our strategic corporate venture fund established in 2017
